Cohort Dashboard

GP2 ist ein Fünfjahresprogramm, das dazu dient, ein besseres Verständnis von der genetischen Architektur der Parkinson-Krankheit zu erlangen, indem diverse Patient*innengruppen genotypisiert und seltene familiäre Parkinson-Formen untersucht werden. Es gibt nach wie vor viel über genetische Risikofaktoren zu lernen und der Weg zu einem besseren Verständnis erfordert einen kooperativen Arbeitsansatz und einen offenen Austausch von Daten, Prozessen und Ergebnissen. Mit diesem Tool können Sie unsere Fortschritte bei der Erfassung verschiedener Kohorten aus aller Welt verfolgen (vierteljährliche Aktualisierung).

Globale Daten gesamt

Einzelne Orte

Kohorten

Erwartete Proben

Abgeschlossene Proben

Letzte Aktualisierung: Originaldesign von GP2 Hackathon 9, 2021 Team. New_-Anastasia-Illarionova-150x150

Showing 10 of 238 cohort studies.

C-OPN

University of Calgary/McGill University | Calgary, Canada

Access Data on AMP® PD

Number of Samples Completed and Expected

Case Samples

384 Completed out of 1,500 Expected

Non-PD Samples

0 Completed out of 0 Expected

Total Samples

384 Completed out of 1,500 Expected

Ancestry Breakdown for Samples Completed

Show

Ancestry	PD Cases	Healthy Controls	Parkinson's Adjacent Disorders	Prodomal	Total Non-PD Samples
aac - african admixed	0	0	0	Pending	0
afr - african ancestry	0	0	0	Pending	0
fin - finnish population isolate	2	0	0	Pending	0
aj - ashkenazi jewish	9	0	0	Pending	0
amr - latino and indigenous people of the americas	4	0	0	Pending	0
eur - general european ancestry	348	0	0	Pending	0
eas - east asian ancestry	6	0	0	Pending	0
sas - south asian ancestry	7	0	0	Pending	0
cas - central asian ancestry	0	0	0	Pending	0
mde - middle eastern ancestry	7	0	0	Pending	0
cah - complex admixture history	1	0	0	Pending	0
total	384	0	0	0	0
Total for all completed samples					384

CALYPSO

University College London | London, United Kingdom

Access Data on AMP® PD

Number of Samples Completed and Expected

Case Samples

179 Completed out of 400 Expected

Non-PD Samples

0 Completed out of 200 Expected

Total Samples

179 Completed out of 600 Expected

Ancestry Breakdown for Samples Completed

Show

Ancestry	PD Cases	Healthy Controls	Parkinson's Adjacent Disorders	Prodomal	Total Non-PD Samples
aac - african admixed	0	0	0	Pending	0
afr - african ancestry	2	0	0	Pending	0
fin - finnish population isolate	0	0	0	Pending	0
aj - ashkenazi jewish	1	0	0	Pending	0
amr - latino and indigenous people of the americas	0	0	0	Pending	0
eur - general european ancestry	173	0	0	Pending	0
eas - east asian ancestry	0	0	0	Pending	0
sas - south asian ancestry	1	0	0	Pending	0
cas - central asian ancestry	1	0	0	Pending	0
mde - middle eastern ancestry	0	0	0	Pending	0
cah - complex admixture history	1	0	0	Pending	0
total	179	0	0	0	0
Total for all completed samples					179

Cambridge Parkinson's Research Clinic

University of Cambridge | Cambridge, United Kingdom

Number of Samples Completed and Expected

Case Samples

0 Completed out of 250 Expected

Non-PD Samples

0 Completed out of 0 Expected

Total Samples

0 Completed out of 250 Expected

CamPaIGN

University of Cambridge | Cambridge, United Kingdom

Number of Samples Completed and Expected

Case Samples

0 Completed out of 142 Expected

Non-PD Samples

0 Completed out of 0 Expected

Total Samples

0 Completed out of 142 Expected

CANDAS

University College London | London, United Kingdom

Number of Samples Completed and Expected

Case Samples

0 Completed out of 244 Expected

Non-PD Samples

0 Completed out of 18 Expected

Total Samples

0 Completed out of 262 Expected

Central Asian and Transcaucasian PD (CAT-PD)

University College London | Almaty, Kazakhstan

Access Data on AMP® PD

Number of Samples Completed and Expected

Case Samples

319 Completed out of 200 Expected

Non-PD Samples

314 Completed out of 200 Expected

Total Samples

633 Completed out of 400 Expected

Ancestry Breakdown for Samples Completed

Show

Ancestry	PD Cases	Healthy Controls	Parkinson's Adjacent Disorders	Prodomal	Total Non-PD Samples
aac - african admixed	0	1	0	Pending	1
afr - african ancestry	0	0	0	Pending	0
fin - finnish population isolate	0	0	0	Pending	0
aj - ashkenazi jewish	0	0	0	Pending	0
amr - latino and indigenous people of the americas	0	19	0	Pending	19
eur - general european ancestry	16	33	0	Pending	33
eas - east asian ancestry	2	0	0	Pending	0
sas - south asian ancestry	0	0	0	Pending	0
cas - central asian ancestry	268	50	2	Pending	52
mde - middle eastern ancestry	12	183	2	Pending	185
cah - complex admixture history	21	24	0	Pending	24
total	319	310	4	0	314
Total for all completed samples					633

Central Asian and Transcaucasian PD (CAT-PD) - Avicena Tajik State Medical University

Avicena Tajik State Medical University | Dushanbe, Tajikistan

Number of Samples Completed and Expected

Case Samples

Pending

Non-PD Samples

Pending

Total Samples

0 Completed out of 0 Expected

Central Asian and Transcaucasian PD (CAT-PD) - Istanbul Klinic

Istanbul Klinic | Baku, Azerbaijan

Number of Samples Completed and Expected

Case Samples

Pending

Non-PD Samples

Pending

Total Samples

0 Completed out of 0 Expected

Central Asian and Transcaucasian PD (CAT-PD) - Kazakh National Medical University

Kazakh National Medical University | Almaty, Kazakhstan

Number of Samples Completed and Expected

Case Samples

Pending

Non-PD Samples

Pending

Total Samples

0 Completed out of 0 Expected

Central Asian and Transcaucasian PD (CAT-PD) - Somnus Movement Disorders Clinic

Somnus Movement Disorders Clinic | Yerevan, Armenia

Number of Samples Completed and Expected

Case Samples

Pending

Non-PD Samples

Pending

Total Samples

0 Completed out of 0 Expected

AMP-PD-Datensatz anfordern

Bei Abschluss der Genotypisierung einer Kohorte durch GP2 werden alle Daten über die gesicherte AMP®-PD-Plattform freigegeben. Registrieren Sie sich, um Zugang zu diesen Daten zu erhalten.

Eine Kohorte einreichen

Wenn Sie gerne mit GP2 zusammenarbeiten möchten, geben wir Ihnen gerne Auskunft darüber, wie Sie eine Kohorte einreichen oder Mitglied werden können.

Überblick über die GP2-Mitglieder auf der ganzen Welt

Erfahren Sie mehr über die Mitglieder der Organisation, die unsere Forschung durch ihre Mitarbeit und die Bereitstellung von Proben und Daten möglich machen.